Clinical Neuroimaging in Psychiatry

References

• Tamminga CA, Dannals RF, Frost JJ, Wong DF, Wagner HN. Neuroreceptor and neurochemistry studies with positron emission tomography in psychiatric illness: promise and progress. Review of psychiatry, JM Oldham, MB Riba, A Tasman. American Psychiatric Press, Washington, DC 1993; 487–510
   Google Scholar
• Roland PE. Brain activation. Wiley-Liss, New York 1993
   Google Scholar
• Andreasen NC. Brain imaging. Review of psychiatry, JM Oldham, MB Riba, A Tasman. American Psychiatric Press, Washington, DC 1993; 311–511
   Google Scholar
• Brain imaging: applications in psychiatry, NC Andreasen. American Psychiatric Press, Washington, DC 1989
   Google Scholar
• Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, et al. Functional cerebral imaging by susceptibility contrast imaging. Magn Reson Med 1990; 14: 538–46
   PubMed Web of Science ®Google Scholar
• Belliveau JW, Kennedy DN, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991; 254: 716–9
   PubMed Web of Science ®Google Scholar
• David A, Blamire A, Breiter H. Functional magnetic resonance imaging: a new technique with implications for psychology and psychiatry. Br J Psychiatry 1994; 164: 2–7
   PubMed Web of Science ®Google Scholar
• Horowitz AL. MRI physics for radiologists: a visual approach. Springer-Verlag, New York 1992
   Google Scholar
• Clinical brain imaging: principles and applications, JC Mazziotta, S Gilman. FA Davis, Philadelphia 1992
   Google Scholar
• Haug JO. Pneumoencephalographic studies in mental disease. Acta Psychiatr Scand 1962; 38: Sl–114, (suppl)
   Google Scholar
• Kraft E, Schillinger A, Finby N, Halperin M. Routine skull radiography in a neuropsychiatric hospital. Am J Psychiatry 1965; 121: 1011–2
   Google Scholar
• Delaney JF. Routine skull films in hospitalized psychiatric patients. Am J Psychiatry 1976; 133: 93–5
   Google Scholar
• Gibby WA, Zimmerman RA. X-ray computed tomography. Clinical brain imaging: principles and applications, JC Mazziotta, S Gilman. FA Davis, Philadelphia 1992; 2–38
   Google Scholar
• Bracewell RN. Strip integration in radio astronomy. Aust J Physico 1956; 9: 188–217
   Google Scholar
• Kuhl DE, Edwards RQ. Image separation isotope scanning. Radiology 1963; 80: 653–61
   Web of Science ®Google Scholar
• DeRosier DJ, Klug A. Reconstruction of three-dimensional structures from electron micrographs. Nature 1968; 217: 130–4
   PubMed Web of Science ®Google Scholar
• Osborn AG. Diagnostic neuroradiology. Mosby-Year Book, St Louis 1994
   Google Scholar
• Zweiman R, Mishkin MM, Hildreth EA. An approach to the performance of contrast studies in contrast material-reactive persons. Ann Intern Med 1975; 83: 159–62
   PubMed Web of Science ®Google Scholar
• Shehadi WH. Adverse reactions to intravenously administered contrast media. AJR Am J Roentgenol 1975; 124: 145–52
   Google Scholar
• Shehadi WH. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 1982; 143: 11–7
   PubMed Web of Science ®Google Scholar
• Witten DM, Hirsch RD, Hartman GW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. AJR Am J Roentgenol 1973; 119: 832–40
   Web of Science ®Google Scholar
• Hayman LA, Evans RA, Fahr LM, Hinck VC. Renal consequences of rapid high dose contrast CT. AJR Am J Roentgenol 1980; 134: 553–5
   Google Scholar
• White RI, Halden WJ. Liquid gold: low-osmolality contrast media. Radiology 1986; 159: 559–60
   Google Scholar
• Bradley WG, Yuh W T C, Bydder GM. Use of MR imaging contrast agents in the brain. J Magn Reson Imaging 1993; 3: 199–218
   Google Scholar
• Hasso AN. Current status of enhanced magnetic resonance imaging in neuroradiology. Invest Radiol 1993; 28(suppl)S3–20
   Google Scholar
• Brasch RC. Introduction to the gadolinium class. J Comput Assist Tomogr 1993; 17(suppl)S14–8
   Google Scholar
• Magin RL, Liburdy RP, Persson B. Biological effects and safety aspects of nuclear magnetic resonance imaging and spectroscopy. Ann N Y Acad Sci 1992; 649: 1–398
   Google Scholar
• Shellock FG, Morisoli S, Kanal E. MR procedures and biomedical implants, materials, and devices: 1993 update. Radiology 1993; 189: 587–99
   Google Scholar
• Melendez C, McCrank E. Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA 1993; 270: 745–7
   PubMed Web of Science ®Google Scholar
• Greenberg SB, Faerber EN, Aspinall CL, Adams RC. High dose chloral hydrate sedation for children undergoing MR imaging: safety and efficacy in relation to age. AJR Am J Roentgenol 1993; 161: 639–41
   Google Scholar
• Klein DS. Prevention of claustrophobia induced by MR imaging: use of alprazolam [Letter]. AJR Am J Roentgenol 1991; 156: 633
   PubMed Web of Science ®Google Scholar
• Reba RC. PET and SPECT: opportunities and challenges for psychiatry. J Clin Psychiatry 1993; 54(suppl)26–32
   Google Scholar
• Kosslyn SM, Alpert NM, Thompson WL, Maljkovic V, Weise SB, Chabris CF, et al. Visual mental imagery activates topographically organized visual cortex: PET investigations. J Cogn Neurosci 1993; 5: 263–87
   PubMed Web of Science ®Google Scholar
• Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter H C R, Savage CR, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen-15 labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62–70
   PubMed Web of Science ®Google Scholar
• Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. Measurement of local cerebral glucose metabolism in man with 18-F-2-fluoro-2-deoxy-D-glucose. Acta Neurol Scand 1977; 56(suppl)190–1
   Google Scholar
• Delforge J, Loc'h C, Hantraye P, Stulzaft O, Khalili-Varasteh M, Maziere M, et al. Kinetic analysis of central [76Br]bromolisuride binding dopamine D2 receptors studied by PET. J Cereb Blood Flow Metab 1991; 11: 914–25
   PubMed Web of Science ®Google Scholar
• Farde L, Norström AL, Wiesel FA, Stefan P, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classic neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992; 49: 538–44
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A, et al. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophr Bull 1988; 14: 471–83
   PubMedGoogle Scholar
• Wong DF, Wagner HN, Tobe LE, Dannals RF, Pearlson GD, Links JM, et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558–63
   PubMed Web of Science ®Google Scholar
• Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 1988; 45: 71–6
   PubMed Web of Science ®Google Scholar
• Wong D, Pearlson G, Young L, Singer H, Villemagne V, Tune L. D2 dopamine receptors are elevated in neuropsychiatric disorders other than schizophrenia [Abstract]. J Cereb Blood Flow Metab 1989; 9(suppl 1)S593
   Google Scholar
• Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, Starkstein SE, et al. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988; 145: 937–43
   PubMed Web of Science ®Google Scholar
• Holman BL, Tumeh SS. Single-photon emission computed tomography (SPECT). JAMA 1990; 263: 561–4
   PubMed Web of Science ®Google Scholar
• Ingvar DH, Lassen NA. Quantitative determination of regional cerebral blood flow in man. Lancet 1961; 2: 806–7
   Google Scholar
• Leonard J-P, Nowotnik DP, Neirinck RD. Technetium-99m-d,1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT: a comparison with iodine-123 HIPDM. J Nucl Med 1986; 27: 1819–23
   PubMed Web of Science ®Google Scholar
• Innis RB. Neuroreceptor imaging with SPECT. J Clin Psychiatry 1992; 53(suppl)29–34
   Google Scholar
• Renshaw PF, Wicklund S. In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol Psychiatry 1988; 23: 465–75
   PubMed Web of Science ®Google Scholar
• Komoroski RA, Newton J E O, Karson C, Cardwell D, Sprigg J. Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy. Biol Psychiatry 1990; 29: 711–4
   Google Scholar
• Renshaw PF, Guimaraes AR, Fava M, Rosenbaum JF, Pearl-Man JD, Flood JG, et al. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am J Psychiatry 1992; 149: 1592–4
   PubMed Web of Science ®Google Scholar
• Pettegrew JW, Keshavan MS, Panchalingham K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high energy phosphate metabolism in first episode, drug naive schizophrenics. Arch Gen Psychiatry 1991; 48: 563–8
   PubMed Web of Science ®Google Scholar
• Kato T, Shiori T, Takahashi S, Inubushi T. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P MRS. J Affect Disord 1991; 22: 185–90
   PubMed Web of Science ®Google Scholar
• Yurgelun-Todd DA, Renshaw PF, Waternaux C, Cohen BM. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res
   Google Scholar
• Renshaw PF, Stoll AL, Rothschild A, Lafer B, Fava M, Rosenbaum JF, et al. Proton MRS studies of the basal ganglia in major depression: side and treatment effects [Abstract]. Proc Soc Magn Res Med 1993; 12: 433
   Google Scholar
• Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993; 187: 433–7
   PubMed Web of Science ®Google Scholar
• Lock T, About-Saleh MT, Edwards R H T. Psychiatry and the new magnetic resonance era. Br J Psychiatry 1990; 157(suppl)S38–55
   Google Scholar
• Keshavan MS, Kapur S, Pettegrew JW. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise. Am J Psychiatry 1991; 148: 976–85
   PubMedGoogle Scholar
• Dager SR, Steen RG. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology 1992; 6: 249–66
   PubMedGoogle Scholar
• Stehling MK, Turner R, Mansfield P. Echo-planar imaging: magnetic resonance imaging in a fraction of a second. Science 1991; 254: 43–9
   PubMed Web of Science ®Google Scholar
• Fox PT, Mintun MA, Raichle ME, Miezin FM, Allman JM, Van Essen DC. Mapping human visual cortex with positron emission tomography. Nature 1986; 323: 806–9
   PubMed Web of Science ®Google Scholar
• Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 1986; 83: 1140–4
   PubMed Web of Science ®Google Scholar
• Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990; 87: 9868–72
   PubMed Web of Science ®Google Scholar
• Kwong KK, Belliveau JW, Chester DA, Goldberg IE, Weisskoff RM, Poncelet BP, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A 1992; 89: 5675–9
   PubMed Web of Science ®Google Scholar
• Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellerman JM, et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. Biophys J 1993; 6: 803–12
   Google Scholar
• Hathout GM, Kirlew K A T, So G J K, Hamilton DR, Zhang JX, Sinha U, et al. MR imaging signal response to sustained stimulation in human visual cortex. J Magn Reson Imaging 1994; 4: 537–43
   Google Scholar
• Breiter HC, Kwong KK, Baker JR, Stern CE, Belliveau JW, Davis TL, et al. Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder [Abstract]. Proc Soc Magn Res Med 1993; 12: 58
   Google Scholar
• Wenz F, Schad LR, Baudendistel K, Flomer F, Schroder J, Knopp MV. Effects of neuroleptic drugs on signal intensity during motor cortex stimulation: functional MR-imaging performed with a standard 1.5 T clinical imager [Abstract]. Proc Soc Magn Res Med 1993; 12: 1419
   Google Scholar
• Renshaw PF, Yurgelun-Todd DA, Cohen BM. Increased hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. Am J Psychiatry 1994; 151: 1493–5
   Google Scholar
• Larson EB, Mack LA, Watts B, Cromwell LD. Computed tomography in patients with psychiatric illnesses: advantage of a “rule-in” approach. Ann Intern Med 1981; 95: 360–4
   PubMed Web of Science ®Google Scholar
• Weinberger DR. Brain disease and psychiatric illness: when should a psychiatrist order a CAT scan. Am J Psychiatry 1984; 141: 1521–7
   PubMed Web of Science ®Google Scholar
• Cunningham Owens DG, Johnstone E, Bydder GM, Kreel L. Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography. J Neurol Neurosurg Psychiatry 1980; 43: 1065–9
   Google Scholar
• Tsai L, Tsuang MT. How can we avoid unnecessary CT scanning for psychiatric patients. J Clin Psychiatry 1981; 42: 452–4
   PubMedGoogle Scholar
• Woods BT. CT scanning in an adult psychiatric population. McLean Hosp J 1976; 1: 150–4
   Google Scholar
• Evans N J R. Cranial computerized tomography in clinical psychiatry: 100 consecutive cases. Compr Psychiatry 1982; 23: 445–50
   Google Scholar
• Holt RE, Rawat S, Beresford TP, Hall R C W. Computed tomography of the brain and the psychiatric consultation. Psychosomatics 1982; 23: 1007–19
   Google Scholar
• Beresford TP, Blow FC, Hall R C W, Nichols LO, Langston JW. CT scanning in psychiatric inpatients: clinical yield. Psychosomatics 1986; 27: 105–12
   PubMed Web of Science ®Google Scholar
• Conlon P, Trimble MR. Magnetic resonance imaging in psychiatry. Can J Psychiatry 1987; 32: 702–12
   Google Scholar
• Garber HJ, Weilburg JB, Buonanno FS, Manschreck TC, New P F J. Use of magnetic resonance imaging in psychiatry. Am J Psychiatry 1988; 145: 164–71
   Google Scholar
• Gerard G, Weinberg LA. MRI periventricular lesions in adults. Neurology 1986; 36: 998–1001
   PubMed Web of Science ®Google Scholar
• Miller BL, Lesser IM, Boone KB, Hill E, Mehringer CM, Wong K. Brain lesions and cognitive function in late-life psychosis. Br J Psychiatry 1991; 158: 76–82
   Google Scholar
• Krishnan K R R. Organic bases of depression in the elderly. Ann Rev Med 1991; 42: 261–6
   Google Scholar
• Welch CA. Electroconvulsive therapy in the general hospital. Handbook of general hospital psychiatry2nd ed., TP Hackett, NH Cassem. PSG, Littleton, Massachusetts 1987; 261–7
   Google Scholar
• Berman KF, Weinberger DR. Functional localization in the brain in schizophrenia. Review of psychiatry, A Tasman, SM Goldfinger, CA Kaufman. American Psychiatric Press, Washington, DC 1991; vol 10: 24–59
   Google Scholar
• Insel TR. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 739–44
   PubMed Web of Science ®Google Scholar
• George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry 1993; 54(suppl)6–13
   Google Scholar
• Jolles PR, Chapman PR, Alavi A. PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications. J Nucl Med 1989; 30: 1589–606
   PubMedGoogle Scholar
• Theodore WH. Epilepsy. Clinical brain imaging: principles and applications, JC Mazziotta, S Gilman. FA Davis, Philadelphia 1992; 136–65
   Google Scholar
• Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, et al. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Arch Gen Psychiatry 1991; 48: 840–7
   PubMedGoogle Scholar
• Pearlson GD, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992; 49: 402–8
   PubMed Web of Science ®Google Scholar
• Herholz K, Perani D, Salmon E, Franck G, Fazio F, Heiss WD, et al. Comparability of FDG PET studies in probable Alzheimer's disease. J Nucl Med 1993; 34: 1460–6
   PubMedGoogle Scholar
• Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33: 181–5
   PubMedGoogle Scholar
• Weinberger DR, Jones D, Reba RC, Man U, Coppola R, Gibson R, et al. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. J Neuropsychiatry Clin Neurosci 1992; 4: 239–48
   PubMed Web of Science ®Google Scholar
• Sackheim HA, Prohovnik I, Moeller JR, Mayeux R, Stern Y, Devanand DP. Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med 1993; 34: 1090–102
   Google Scholar